Alvogen, a privately owned US-based pharmaceutical company, is dedicated to developing, in-licensing, manufacturing, and marketing high-quality pharmaceutical products. With a focus on complex inhalation, injectables, and strategic 505 b 2 products, Alvogen has over 50 products on the market and a robust pipeline driven by extensive R&D capabilities.
Founded by Robert Wessman during the financial crisis of 2009, Alvogen's mission is to improve people's lives by providing accessible, top-notch medicines that promote longevity, health, and vitality. Emphasizing partnerships and collaboration, Alvogen is committed to setting a new standard in the pharmaceutical industry through strategic alliances and a dedication to making a positive impact on global healthcare.
Generated from the website